Inventor · disambiguated record
Bandar Aldhubiab
Also filed as: ALDHUBIAB BANDAR · ALDHUBIAB BANDAR E
18 granted patents·2 citations·filing 2023–2024
86Inventor score
Top patents by PatentIndex Score
18 records- 0192US11807640B17-isopropyl 1-ethyl/methyl 3-(substituted benzoyl)-2-substituted indolizine-1,7-dicarboxylates as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Nov 7, 2023·2 cites·16 claims
- 0277US11964982B15-(3-substituted phenyl)-pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione derivatives as anticancer agentsUNIV KING FAISAL·Filed 2023·Granted Apr 23, 2024·0 cites·6 claims
- 0377US11884677B15-(substitutedphenyl)-7-imino-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agentsUNIV KING FAISAL·Filed 2023·Granted Jan 30, 2024·0 cites·14 claims
- 0475US12297204B25-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agentsUNIV KING FAISAL·Filed 2024·Granted May 13, 2025·0 cites·8 claims
- 0575US12221450B15-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agentsUNIV KING FAISAL·Filed 2024·Granted Feb 11, 2025·0 cites·14 claims
- 0674US11919860B11-2(-(substituted phenyl)-2-oxoethyl)-4-(isopropoxycarbonyl)pyridin-1-ium bromides as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Mar 5, 2024·0 cites·16 claims
- 0773US12187733B15-(Substitutedphenyl)-7-Imino-7,8-Dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agentsUNIV KING FAISAL·Filed 2023·Granted Jan 7, 2025·0 cites·8 claims
- 0872US11932649B15-(3-substituted phenyl)-pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione derivatives as anticancer agentsKING FAISAL UNIVERISTY·Filed 2023·Granted Mar 19, 2024·0 cites·13 claims
- 0972US11926602B14-amino-5-(4-fluoro-3-phenoxyphenyl)-4H-1,2,4-triazole-3-thiol derivatives as antifungal agentsUNIV KING FAISAL·Filed 2023·Granted Mar 12, 2024·0 cites·10 claims
- 1072US11926627B1Substituted 7-methyl quinoline derivatives as antitubercular agentsUNIV KING FAISAL·Filed 2023·Granted Mar 12, 2024·0 cites·14 claims
- 1171US11845746B1Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Dec 19, 2023·0 cites·8 claims
- 1270US12227480B11-(2-(substituted phenyl)-2-oxoethyl)-4-methylpyridin-1-ium bromide as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Feb 18, 2025·0 cites·5 claims
- 1370US11945819B1Dimethyl 7-bromo-1-(4-substituted benzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylates as anti-inflammatory agentsUNIV KING FAISAL·Filed 2023·Granted Apr 2, 2024·0 cites·17 claims
- 1469US11939294B11-(2-(substituted phenyl)-2-oxoethyl)-3,5-dimethylpyridin-1-ium bromides as antitubercular agentsUNIV KING FAISAL·Filed 2023·Granted Mar 26, 2024·0 cites·8 claims
- 1567US11919900B11-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agentsUNIV KING FAISAL·Filed 2023·Granted Mar 5, 2024·0 cites·17 claims
- 1666US11938120B1Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Mar 26, 2024·0 cites·16 claims
- 1766US11807553B1Decontamination of water using guar gum derivatives and applications thereofUNIV KING FAISAL·Filed 2023·Granted Nov 7, 2023·0 cites·10 claims
- 1863US11974991B1Adenosine receptor activity of methyl/ethyl 3-(substituted benzoyl)-6,8-dimethylindolizine-2-substituted-1-carboxylatesUNIV KING FAISAL·Filed 2023·Granted May 7, 2024·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Bandar Aldhubiab files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →